Biolizin for Improving Functional Poor Appetite in Children Aged 6 to 36 Months (CTBE2502) (CTBE2502)
A Parallel-Group, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of a Zinc-Containing Dietary Supplement (Biolizin) in Improving Functional Poor Appetite in Children Aged 6 to 36 Months
Sponsor: Haiphong University of Medicine and Pharmacy
A NA clinical study on Appetite Disorders and Feeding and Eating Disorders of Childhood, this trial is actively recruiting participants. The trial is conducted by Haiphong University of Medicine and Pharmacy and has accumulated 2 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
2 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2025 — Feb 2026 [monthly]
Not Yet Recruiting NA
First recorded
Sep 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Haiphong University of Medicine and Pharmacy
For direct contact, visit the study record on ClinicalTrials.gov .